132 related articles for article (PubMed ID: 35578724)
1. KIF22 Promotes Development of Pancreatic Cancer by Regulating the MEK/ERK/P21 Signaling Axis.
Zhang R; Ma L; Wei Y; Wei K; Song T; Du Z; Feng Z
Biomed Res Int; 2022; 2022():6000925. PubMed ID: 35578724
[TBL] [Abstract][Full Text] [Related]
2. Effect of KIF22 on promoting proliferation and migration of gastric cancer cells via MAPK-ERK pathways.
Yu ZY; Jiang XY; Zhao RR; Qin JJ; Luo CJ; Ren YX; Ren W; Ma ZJ; Jiao ZY
Chin Med J (Engl); 2020 Apr; 133(8):919-928. PubMed ID: 32187050
[TBL] [Abstract][Full Text] [Related]
3. KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway.
Zhai M; Miao J; Zhang R; Liu R; Li F; Shen Y; Wang T; Xu X; Gao G; Hu J; He A; Bai J
J Cancer Res Clin Oncol; 2024 May; 150(5):239. PubMed ID: 38713252
[TBL] [Abstract][Full Text] [Related]
4. KIF22 promotes bladder cancer progression by activating the expression of CDCA3.
Li K; Li S; Tang S; Zhang M; Ma Z; Wang Q; Chen F
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34633053
[TBL] [Abstract][Full Text] [Related]
5. KIF22 promotes the proliferation and glycolysis of melanoma by activating EGFR/STAT3 signaling.
Zhong Z; Zhong H
Clinics (Sao Paulo); 2023; 78():100307. PubMed ID: 37944197
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of long non-coding RNA MALAT1 inhibits granulosa cell proliferation in endometriosis by up-regulating P21 via activation of the ERK/MAPK pathway.
Li Y; Liu YD; Chen SL; Chen X; Ye DS; Zhou XY; Zhe J; Zhang J
Mol Hum Reprod; 2019 Jan; 25(1):17-29. PubMed ID: 30371869
[TBL] [Abstract][Full Text] [Related]
7. MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac.
Yip-Schneider MT; Schmidt CM
Pancreas; 2003 Nov; 27(4):337-44. PubMed ID: 14576498
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E2 modulates cell cycle function to promote proliferation in pancreatic cancer cells via regulation of the c-Myc-p21
Du S; Wang H; Cai J; Ren R; Zhang W; Wei W; Shen X
Biochem Cell Biol; 2020 Apr; 98(2):191-202. PubMed ID: 32167787
[TBL] [Abstract][Full Text] [Related]
9. [Effects of extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activation on proliferation and cell cycle associated genes in human colon cancer cells].
Wang X; Lu R; Fang JY
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):982-6. PubMed ID: 17650425
[TBL] [Abstract][Full Text] [Related]
10. MEK/ERK-mediated proliferation is negatively regulated by P38 map kinase in the human pancreatic cancer cell line, PANC-1.
Ding XZ; Adrian TE
Biochem Biophys Res Commun; 2001 Mar; 282(2):447-53. PubMed ID: 11401480
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
Gysin S; Lee SH; Dean NM; McMahon M
Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
[TBL] [Abstract][Full Text] [Related]
12. On the mechanisms of 12-O-tetradecanoylphorbol-13-acetate-induced growth arrest in pancreatic cancer cells.
Salabat MR; Ding XZ; Flesche JB; Ujiki MB; Robin TP; Talamonti MS; Bell RH; Adrian TE
Pancreas; 2006 Aug; 33(2):148-55. PubMed ID: 16868480
[TBL] [Abstract][Full Text] [Related]
13. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
14. Analysis of invasion-metastasis mechanism in pancreatic cancer: involvement of tight junction transmembrane protein occludin and MEK/ERK signal transduction pathway in cancer cell dissociation.
Tan X; Tamori Y; Egami H; Ishikawa S; Kurizaki T; Takai E; Hirota M; Ogawa M
Oncol Rep; 2004 May; 11(5):993-8. PubMed ID: 15069537
[TBL] [Abstract][Full Text] [Related]
15. Ski promotes tumor growth through abrogation of transforming growth factor-beta signaling in pancreatic cancer.
Heider TR; Lyman S; Schoonhoven R; Behrns KE
Ann Surg; 2007 Jul; 246(1):61-8. PubMed ID: 17592292
[TBL] [Abstract][Full Text] [Related]
16. A mortalin/HSPA9-mediated switch in tumor-suppressive signaling of Raf/MEK/extracellular signal-regulated kinase.
Wu PK; Hong SK; Veeranki S; Karkhanis M; Starenki D; Plaza JA; Park JI
Mol Cell Biol; 2013 Oct; 33(20):4051-67. PubMed ID: 23959801
[TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of MAPK/ERK in the specimens and cells of epithelial ovarian cancer].
Jiang XL; Gao JC; Jiang L; Zhang PX; Kang TJ; Sun Q; Qi WJ; Zhang QP; Guan HW; Shi H
Zhonghua Fu Chan Ke Za Zhi; 2019 Aug; 54(8):541-547. PubMed ID: 31461811
[No Abstract] [Full Text] [Related]
18. Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling.
Wang F; Wang L; Qu C; Chen L; Geng Y; Cheng C; Yu S; Wang D; Yang L; Meng Z; Chen Z
BMC Cancer; 2021 Apr; 21(1):396. PubMed ID: 33845796
[TBL] [Abstract][Full Text] [Related]
19. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
20. KIF15 promotes pancreatic cancer proliferation via the MEK-ERK signalling pathway.
Wang J; Guo X; Xie C; Jiang J
Br J Cancer; 2017 Jul; 117(2):245-255. PubMed ID: 28595260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]